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In mammalian and amphibian oocytes, the meiotic arrest at the G2/M transition is dependent on cAMP regulation. Because genetic inactivation
of a phosphodiesterase expressed in oocytes prevents reentry into the cell cycle, suggesting autonomous cAMP synthesis, we investigated the
presence and properties of the G-protein-coupled receptors (GPCRs) in rodent oocytes. The pattern of expression was defined using three
independent strategies, including microarray analysis of GVoocyte mRNAs, EST database scanning, and RT-PCR amplification with degenerated
primers against transmembrane regions conserved in the GPCR superfamily. Clustering of the GPCR mRNAs from rat and mouse oocytes
indicated the expression of the closely related Gpr3, Gpr12, and Edg3, which recognize sphingosine and its metabolites as ligands. Expression of
these mRNAs was confirmed by RT-PCR with specific primers as well as by in situ hybridization. That these receptors are involved in the control
of cAMP levels in oocytes was indicated by the finding that expression of the mRNA for Gpr3 and Gpr12 is downregulated in Pde3a-deficient
oocytes, which have a chronic elevation of cAMP levels. Expression of GPR3 or GPR12 in Xenopus laevis oocytes prevented progesterone-
induced meiotic maturation, whereas expression of FSHR had no effect. A block in spontaneous oocyte maturation was also induced when Gpr3
or Gpr12 mRNA was injected into mouse oocytes. Downregulation of GPR3 and GPR12 caused meiotic resumption in mouse and rat oocytes,
respectively. However, ablation of the Gpr12 gene in the mouse did not cause a leaky meiotic arrest, suggesting compensation by Gpr3.
Incubation of mouse oocytes with the GPR3/12 ligands SPC and S1P delayed spontaneous oocyte maturation. We propose that the cAMP levels
required for maintaining meiotic arrest in mouse and rat oocytes are dependent on the expression of Gpr3 and/or Gpr12.
D 2005 Elsevier Inc. All rights reserved.Keywords: Oocyte; Meiosis; cAMP; G-protein-coupled receptors; Mouse; RatIntroduction
In the fully developed antral follicles of the mammalian
ovary, oocytes are arrested in meiotic prophase in spite of being
fully competent to resume meiosis (Eppig, 1993; Tsafriri and
Dekel, 1994). Removal of the oocytes from their follicular
environment causes resumption of meiosis and maturation
(Pincus and Enzmann, 1935) to yield an egg fully competent
for fertilization and embryo development (Eppig, 1993; Tsafriri
and Dekel, 1994). The LH surge is the signal that triggers
oocyte reentry into the cell cycle prior to ovulation. Because
LH receptors are present only on the granulosa cells of the0012-1606/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
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pin signal from somatic cells to the oocyte (Park et al., 2004).
It is generally accepted that cAMP signaling plays an
important role in maintaining this meiotic arrest (reviewed in
Conti et al., 2002). This hypothesis was initially based on
pharmacological manipulation of cAMP levels in oocytes
during in vitro spontaneous maturation (Cho et al., 1974;
Dekel and Beers, 1978; Schultz et al., 1983; Vivarelli et al.,
1983) and in vivo maturation induced by the LH surge
(Wiersma et al., 1998). More recently, it has been shown that
injection of inhibitory Gs antibodies into mouse oocytes still
enclosed in the follicle causes germinal vesicle breakdown
(GVBD) (Mehlmann et al., 2002). This seminal observation
demonstrates that oocytes are autonomous in terms of cAMP
production and implies that an active Gs protein and adenylyl
cyclase are required to maintain meiotic arrest. Indeed, genetic87 (2005) 249 – 261
www.e
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gene in the mouse produces a leaky meiotic arrest (Horner et
al., 2003). In the same vein, genetic ablation of the major PDE
expressed in mouse oocytes causes complete female sterility
due to ovulation of immature GV-arrested oocytes that cannot
be fertilized by spermatozoa (Masciarelli et al., 2004).
Pde3a-deficient oocytes do not undergo meiotic maturation
even after prolonged incubation in vitro or after ovulation and
transfer to the ampulla, suggesting that the meiotic block is
maintained autonomously by the oocyte outside the follicle
(Masciarelli et al., 2004). This block is most likely due to
constitutive cAMP signaling because increased cAMP in these
oocytes was associated with undetectable cAMP-PDE activity.
That this block is dependent on the presence of an active
adenylyl cyclase and Gs protein is suggested by the observa-
tion that inhibition of Gs by injection of a Gsa inhibitory
antibody in the Pde3a-deficient oocytes causes GVBD and a
prompt reentry into the cell cycle (Mehlmann and Jaffe,
personal communication). Similarly, inhibition of steps down-
stream of cAMP, such as PKA catalytic activity, restores
meiotic maturation in these oocytes (Masciarelli et al., 2004).
Taken together, the above findings strongly suggest that
meiotic arrest is dependent on continuous cAMP signaling
through active Gs/adenylyl cyclase endogenous to the oocyte.
An extension of this hypothesis is that one or more receptors
involved in the regulation of cAMP are expressed in oocytes.
Since these receptors should signal through a Gs protein, they
likely belong to the family of GPCRs with the characteristic
seven transmembrane domain motifs. Given the continuous
cAMP accumulation and meiotic arrest of the Pde3a-null
oocytes even after removal from the follicle and the observa-
tion that a Gsa inhibitory antibody promotes maturation in
denuded oocytes, we speculated that these GPCRs have
significant activity toward Gs even in the absence of a putative
ligand produced by the somatic cells of the follicle.
To test this possibility, we have used several independent
approaches to define the pattern of GPCR expression in rodent
oocytes arrested in meiotic prophase. Here, we show that a
subfamily of GPCRs that bind the ubiquitous lysophospholipid
mediators is expressed in GV stage mouse and rat oocytes.
These receptors show constitutive activity toward Gs when
expressed in a heterologous system, and their overexpression
blocks oocyte maturation in Xenopus and mouse oocytes.
Major differences in the expression and function of GPR3 and
GPR12 were found in mouse and rat, suggesting that their
involvement in meiotic arrest is species-specific.
Materials and methods
Animal treatments, collection of oocytes, cumulus cells, and granulosa
cells
All animal procedures were in accordance with accepted standards of
humane animal care and were approved by the Institutional Animal Care and
Use Committee at Stanford University.
Immature (23-day-old) C57Bl/6 mice or Sprague–Dawley rats were primed
with 5 or 10 IU PMSG, respectively. After 45 h, ovaries were excised in L-15
Liebovitz’s medium (L-15) (Invitrogen, Carlsbad, CA) with 5% fetal bovine
serum (FBS), 100 U/ml penicillin, and 100 U/ml streptomycin. FBS wassubstituted with 0.7% polyvinylpyrrolidone (PVP) (Sigma, St. Louis, MO) for
ligand studies or with 0.3% fatty acid-free BSA (FAF-BSA) (Sigma) for
injection studies. Antral follicles were punctured with a needle, and cumulus–
oocyte complexes (COCs) were aspirated and stripped of cumulus cells by
repeated pipetting with a small bore pipette. Denuded oocytes were washed free
of all cells by transferring to successive dishes of medium. For cumulus cell
collection, COCs were separated from mural granulosa cells and then stripped.
Granulosa cells were collected from the punctured ovaries after removing the
ovaries and COCs.
Gpr12-deficient mice were generated by Deltagen (Palo Alto, CA;
construct T341). A deletion of approximately 500 bp was introduced by
insertion of the IRES-lacZ reporter and neomycin resistance cassette. The
Gpr12-null allele of the mice used in our studies was maintained on a C57Bl/6J
background. Mice were genotyped by extracting tail DNA using two PCR
reactions designed to detect wild-type and targeted alleles.
Screening for GPCR mRNA expression in rodent oocytes
Oocytes were collected from PMSG-treated immature C57Bl/6 mice and
Sprague–Dawley rats as described above. Denuded oocytes (2000) were used
for RNA extraction within 30 min after follicle puncture following the protocol
for TRIzol reagent (Invitrogen). RNA was quantified by optical density at 260
nm, and RT reactions were performed with approximately 100 ng of RNA
using random hexamers. The cDNA thus obtained was used for RT-PCR with
the following primers designed on the basis of the conservation of sequences in
transmembrane domains 3 (TM3) and 6 (TM6) of GPCRs (TM3 = 5V-CT(G/C)
CT(G/C) G(C/T)(C/G) AT(C/T) GCI (G/C)T(G/C) GA(C/T) (C/A)GI TA-3V;
TM6 = 5V-(G/A)(A/T)A IGG (C/G)AG CCA (G/A)CA (G/C)A(T/C) IG(C/T)
(G/A)AA-3V. The PCR conditions were as follows: 30 cycles of 94-C for 1 min,
55-C for 1 min, 72-C for 3 min, then elongation at 72-C for 7 min. The
amplified fragments corresponding to approximately 450 bp were purified from
a 1.5% agarose gel and subcloned into pCR2.1-TOPO vector (Invitrogen).
Random colonies were picked, plasmid purified, and used for sequencing. The
nucleotide sequences were performed by Biotech Core (Mountain View, CA)
with an ABI automated DNA sequencer. Sequences were analyzed for identity
using the CLUSTAL algorithm, and the identities were determined by BLAST
analysis.
Murine Genome U74Av2 GeneChips microarray data generated using GV
or MII oocyte RNA were obtained from Wang et al. (2004). Records were
scanned for G-protein-coupled receptor entries. The P call% was ignored for
genes coding for GPCR whose expression levels were calculated above the
1000 value (Wang et al., 2004). Entries that were below 1000 and called absent
by the Affimetrix program were not included.
The following data sets of expressed sequence tags (dbEST) derived from
mouse oocyte and egg cDNA libraries were searched: Mouse GV Oocyte
Libraries NIH_MGC_256 and NIH_MGC_257, dbEST Library 10029, NIA
Mouse Unfertilized Egg cDNA Library (Long), dbEST Library 14142, NIA
Mouse Unfertilized Egg cDNA Library (Long 1), and dbEST Lib.1389 Mouse
Unfertilized Egg cDNA Library. Using this strategy, ESTs corresponding to the
following GPCRs were retrieved: Gpr1, Gpr3, Gpr35, Gpr56, Gpr108,
Gpr116, Gpr125, Gpr133, Oprm1, and Lgr6. The EST accession numbers
which overlap with the microarray data are reported in Table 1.
RT-PCR with GPCR-specific primers
To confirm the presence and compare the expression of each gene in the
different cell types of the ovary, the Cell-to-cDNA kit (Ambion, Austin, TX)
was used to perform RT-PCR on 60 denuded oocytes from mouse and rat and
on cumulus and mural granulosa cells from 6 mouse ovaries. The cDNA from
the three cell types was prepared from four different cell collections and
normalized to b-actin. In several experiments, 1000–2000 oocytes from wild-
type and Pde3a-deficient mice were also collected, and total RNA was
extracted according to the protocol for TRIzol reagent. RT reactions were
performed with 0.3–1 Ag of RNA using random hexamers. The quantity of
RNA was measured by optical density at 260 nm, and the amount of cDNA
used in the PCR was normalized to b-actin. To control for genomic DNA
contamination, PCRs were performed with gene-specific primers on RNA
without reverse transcriptase treatment. The cDNA prepared from rat and
Table 1
GPCR gene expression in mouse oocytes
Gene
name
Description Accession
number
Alternative names G-protein
coupling
Ligands Microarray
mRNA T SEM
ESTs RT-PCR
Adora2a Adenosine A2a
receptor
NM009630 Adora2a A2aR Gs Adenosine 901 T 100 CO807420.1 Present
Mc1r Melanocortin 1
receptor
X65635 Mc1r, e, Tob, Mshra
tobacco darkening
Gs MSH 709 T 85
Mc5r Melanocortin 5 receptor U08354 Mc5r Gs MSH 1162 T 132
Gpr3 G-protein-coupled
receptor 3
D21062 GPCR 21,ACCA Gs,Gq/11,Gi S1P 4594 T 432 BB709334 Present
Gpcr12 G-protein-coupled
receptor 12
D21061 GPCR01 Gs,Gq/11,Gi SPC,S1P,
DHS1P
8408 T 376 Present
Edg3 EDG-3 AF108021 LPb3, S1P3 Gq/11, Gi/o S1P,DHS1P 1983 T 268 Present
Gpr50 G-protein-coupled
receptor 50
AF065145 H9, melatonin-related
receptor
? 4734 T 304
Adrb2 Adrenergic receptor,
beta 2
X15643 Adrb2,Badm, Gpcr7,
Adrb-2, beta 2-AR
Gs Catecholamine 1329 T 156
Htr5a 5-Hydroxytryptamine
(serotonin) receptor 5A
Z18278 Htr5 Gi/o Serotonin 873 T 81
Hrh1 Histamine receptor H1 D50095 Bphs, Bordetella
pertussis-induced
histamine sensitization
Gs Histamine 831 T 146
Gpr27 G-protein-coupled
receptor 27
AF027955 Sreb1 ? 2388 T 226
Ptger2 Prostaglandin E receptor
EP2 subtype
D13458 Prostaglandin E receptor2
(EP4 subtype), Pter4
Prostaglandin E 433 T 125
Npy2r Neuropeptide Y
receptor Y2
D86238 NPY-Y2 receptor Gi/o Neuropeptide Y 247 T 36
Cckar Cholecystokinin A
receptor
D85605 Gs,Gq/11 CCK-A 369 T 41
Cckbr Cholecystokinin B
receptor
AF019371 Cck2/gastrin receptor,
Cck-B/gastrin receptor
Gq/11 CCK-B 2453 T 114
Sstr4 Somatostatin receptor 4 U26176 Sst4, Smstr4 Gi/o Somatostatin 3070 T 200
Oprd1 Opioid receptor, delta 1 L11064 Gi/o Opioid 695 T 88
Oprs1 Opioid receptor, sigma 1 AF004927 mSigmaR1 Opioid 1697 T 180
Cxcr3 Chemokine (C-X-C)
receptor 3
AF045146 CXCR3, Cd183, Cmkar3 Chemokine 4053 T 172
Bdkrb2 Bradykinin receptor, beta L26047 kinin B2, B2, B2R, Bradykinin 2781 T 303
Cmkor1 Chemokine orphan
receptor 1
AF000236 Rdc1 Chemokine 356 T 43
Admr Adrenomedullin receptor D17292 NOW, AM-R, MB10,
G10-D, Gpcr17,Gpcr22
Adrenomedullin 1100 T 125
Gpr44 G-protein-coupled
receptor 44
AF054507 Crth2, Gpr45 2328 T 259
Olfr157 Olfactory receptor 37c AJ133426 Olfactory rec. 157
OR37C, mOR37c
1219 T 133
Olfr158 Olfactory receptor 37d AJ133427 Olfactory rec. 158,
mOr37d, Olfr37d
2198 T 183
Olfr71 Olfactory receptor 71 (17) AJ133429 Olfactory rec. 71,
mOr17, Mor262-4
7561 T 899
Gpr19 G-protein-coupled
receptor 19
U46923 3380 T 374
Gcgr Glucagon receptor L38613 Gr Gs Glucagon 2640 T 79
Ghrhr Growth hormone
releasing hormone
receptor
L07379 Ghrhr, lit, Ghrfr Gs GHRH 791 T 99
Gpr56 G-protein-coupled
receptor 56
BC021648 Serpentine receptor 6966 T 826 CO797582.1 Present
Grm8 G-protein-coupled
receptor, family C,
group 1, member H
U17252 Glutamate receptor,
metabotropic 8, Gprc1h
Gi/o Glutamate 582 T 47 CO809126.1,
CO804286.1
The levels of mRNA expression for each GPCR were determined by analyzing a microarray data set of RNAs from GV oocytes hybridized to Murine Genome
U74Av2 GeneChips (Wang et al., 2004). The microarray data used to generate this table are present in the public database ArrayExpress (http://www.ebi.ac.uk/
arrayexpress). When the expression of a GPCR was detected both through EST database scanning and microarray analysis, the matching EST accession number is
indicated in the corresponding column. The last column indicates the GPCRs that were detected by RT-PCR of mouse and/or rat GV oocyte mRNA.
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GPCRs in the two species. For amplification of GPCRs, gene-specific primers
5V-GACATTGTCTTGTGCAGCTCAGGA-3V and 5V-GCGTAAATGA-
CAGGGTTGATGATGGA-3V were used to confirm the presence of Gpr12;
primers 5V-GTGGTGCTGTGCATCTCAGGCA-3V and 5V-GGTTGATCATG-
GAGTTGTAGGT-3V were used for Gpr3; primers 5V-CTGGCCATTGCCATT-
GAGCGACAC-3V and 5V-ACCAACAGGCAATGAACACACTCA-3V were
used for Edg-3; and primers 5V-GAGGATCTGCATATCCACTCCCAG-3V
and 5V-GAGTGGCTTCTACCTCTGTGGATG-3V were used for Gpr56. The
PCR conditions were a hot start at 94-C for 3 min and 35 cycles of 94-C for 1
min, 62-C for 1 min, and 72-C for 1 min, and 72-C for 6 min. To confirm the
identity of the receptors, bands of 763, 725, 317, and 455 bp for Gpr12, Gpr3,
Edg3, and Gpr56, respectively, were purified from agarose gels, cloned into
pCRII-TOPO vectors (Invitrogen), and sequenced. For semiquantitative
analysis, the number of amplification cycles was chosen in the exponential
phase of amplification for each primer pair. These experiments evaluating the
expression of Gpr3 and Gpr12 were repeated with additional pairs of primers,
5V-TCTATGGCCTGGTTCTCAGCTG-3V and 5V-GCATTGTACAGGAAAGG-
TAGCG-3V, and 5V-CACCAAGCTGGTCACCATCG-3V and 5V-GCGTG-
CCTCATCACAATCTTACA-3V, respectively. PCR products visualized on
ethidium bromide–agarose gels were analyzed using NIH Image (Scion,
Frederick, MD) to compare the densities of the bands.
Maturation studies
Sphingosylphosphorylcholine (SPC) (Biomol, Plymouth Meeting, PA) was
dissolved in water, and sphingosine-1-phosphate (S1P) (Biomol) and sphingo-
myelin (SM) (Biomol) were prepared as liposomes, according to the manufac-
turer’s instructions. Denuded oocytes were collected in L-15 medium with 0.7%
PVP with or without 1 or 10 AM SPC or S1P or 10 AM SM and placed in 25
Al drops of the same medium under mineral oil. From the time of puncture of the
follicles, the oocytes were scored for meiotic maturation every 15 min for 2 h.
Progression of meiotic maturation of denuded mouse oocytes was scored by
monitoring the breakdown of germinal vesicles (GVBD) with an inverted
microscope (Olympus, Melville, New York) fitted with a Hoffman contrast
lens. Oocytes showing clear nuclear membranes (germinal vesicle, GV) and
nucleoli were classified as GV stage; those without visible nuclear structure,
i.e., exhibiting germinal vesicle breakdown (GVBD), were classified as GVBD
stage; and metaphase II-arrested oocytes, with a polar body (PB), were
classified as MII. Time 0 was the time of follicle puncture.
In situ hybridization
Ovaries of 25-day-old PMSG-treated mice and rats were fixed in 4%
paraformaldehyde for 6 h followed by incubation in 0.5 M sucrose in PBS
overnight at 4-C as previously described (Park et al., 2003). The ovaries were
embedded in OCT (Tissue-Tek, Redding, CA), cut into 10 Am sections, and
mounted on Superfrost slides (Fisher, Pittsburgh, PA). Slides were prepared for
hybridization as previously described (1). The Gpr3 and Gpr12 cDNA (725
and 763 bp, respectively) were subcloned into pCRII-TOPO vector (Invitro-
gen), linearized, and transcribed to synthesize [35S]-labeled RNA probes.
Hybridization mixtures with antisense and sense RNA probes were added to the
slides and incubated overnight at 65-C. Post-hybridization washes consisted of
RNaseA treatment and decreasing concentrations of SSC washes. Hybridized
slides were then dehydrated and dried. Slides were dipped into NTB2 Emulsion
(Eastman Kodak, Rochester, NY), exposed for 1 –8 days, developed
photographically, and then counterstained with Harris Hematoxylin and EosinY
(0.125% in ethanol). Following counterstaining, tissues were cleared with
xylene, mounted with Permount (Fisher, Fair Lawn, NJ), visualized, and
photographed with AxioCam (Zeiss, Oberkochen, Germany).
Cloning of mouse Gpr3 and Gpr12 cDNA into mammalian expression
vectors and transient transfection in COS7 cells
Full-length cDNA of murine Gpr3 was amplified by PCR from mouse
brain cDNA and cloned into pcDNA3-V-5 or pGEMHE vectors. Primers used
were the gene-specific primers 5V-ACCATGATGTGGGGAGCAGGAAGCT-3Vand 5V-GTAGACATCACTAGGGGACCGGGA-3V. Clones for pGEMHE-
Gpr12 with and without signal peptide (SP) were provided by Dr. Chica
Schaller (Ignatov et al., 2003) and were subcloned into pcDNA3-V-5 for
mammalian expression. All constructs were sequenced to ensure correct
insertion and sequence.
COS7 cells were cultured at 37-C in a 5% CO2 atmosphere in DMEM
(Dulbecco’s modified Eagle’s medium) (Gibco, Grand Island, NY) supple-
mented with 10% fetal calf serum, 100 U/ml penicillin, and 100 U/ml
streptomycin. For recombinant expression of GPCR constructs in COS7, cell
cultures were grown on 6-well plates to 30% confluency and were then
transfected with the following recombinant plasmids using the Effectene
transfection system (Invitrogen) according to the manufacturer’s protocol with
0.5 Ag of DNA: pCDNA3, pCDNA3-SP-Gpr12, pcDNA3-SP-Gpr3, pcDNA3-
hfshr, or pcDNA3-Adrb2 (h-adrenergic receptor). Two days after transfection,
the medium was changed to DMEM without serum. After a further 24 h, cells
were incubated in medium with 0.5 mM IBMX with varying concentrations of
SPC or S1P (0.1–10 AM) for cells transfected with Gpr12 or Gpr3, or with
hFSH (100 ng/ml) added to the Fshr transfected cells. Cells were harvested for
cAMP quantification after 30 min.
Measurement of cAMP content in COS7 cells
Transfected cells were scraped in 1 ml of cold 0.1% TCA in 95% EtOH
followed by centrifugation at 3000 rpm for 30 min at 4-C. The supernatant
was evaporated and reconstituted in 1 ml PBS. After acetylation, cAMP
content was measured by radioimmunoassay (Harper and Brooker, 1975). The
pellet was dissolved in 0.5 ml 1% NaOH, and the protein content was
determined by a modified Lowry colorimetric assay (Bensadoun and
Weinstein, 1976).
Injection of RNA into mouse oocytes
Capped mRNAs were prepared from pEgfp and full-length coding
regions of mGpr3 and mGpr12 cloned into pcDNA3 with the mMessage
mMachine kit (Ambion), purified with RNeasy kit (Qiagen, Valencia, CA),
and diluted to 0.5 Ag/Al. Using an IM-300 Microinjector (Narishige
International, East Meadow, NY) and sterile pipettes, 10–15 pl of mRNA
was microinjected into the cytoplasm of denuded GV oocytes in M2
medium (Specialty Media, Phillipsburg, NJ) with 0.3% FAF-BSA and 10 AM
cilostamide (Sigma). Following microinjection, oocytes were transferred to
a-MEM medium (Invitrogen) with 10 AM cilostamide and 0.3% FAF-BSA
and incubated for 4 h at 37-C in 5% CO2. After incubation, morpho-
logically normal oocytes were washed extensively in L-15 medium with
0.3% FAF-BSA without cilostamide and cultured for 24 h at 37-C in
humidified air. The meiotic progression was scored every 15 min for the
first 4 h using an Olympus inverted microscope fitted with a Hoffman
contrast lens at 200.
Injection of morpholino oligonucleotides in mouse and rat oocytes
For targeted knockdown of the GPR3 and GPR12 proteins, antisense
morpholino oligonucleotides (MO) (Gpr3MO and Gpr12MO) (mouse Gpr3:
5V-AGCTTCCTGCTCCCCACATCATG-3V, rat Gpr3: 5V-GTCTTCGTTCATT-
TTAACCCCTGTC-3V and mouse/rat Gpr12 : 5V-GTCTTCGTTCATTTT-
AACCCCTGTC-3V), corresponding to 25 nucleotides surrounding the ATG
initiation codon of mouse Gpr3 and Gpr12 (NM_008154 and NM_008151,
respectively) and rat Gpr3 and Gpr12 (NM_153727 and NM_030831,
respectively), were purchased from Gene Tools (Philomath, OR). The standard
control morpholino oligonucleotide with the sequence 5V-CCTCTTACCT-
CAGTTACAATTTATA-3V (Gene Tools) was used for control injections. All
oligonucleotides were dissolved in nuclease-free water at a concentration of 1
mM and stored at 80-C in 2 Al aliquots. 10–15 pl of the indicated MO was
injected into the cytoplasm of the oocytes in M2 medium supplemented with
0.3% FAF-BSA and 4.5 mM hypoxanthine. Immediately after injection,
oocytes were transferred to a-MEM medium supplemented with 0.3% FAF-
BSA and 4.5 mM hypoxanthine, incubated at 37-C in 5% CO2, and meiotic
progression was scored up to 48 h.
Fig. 1. Phylogenetic analysis of mouse S1P family of receptors and closely
related receptors expressed in mouse oocytes. The phylogenetic tree was
generated by CLUSTAL/W and BLOCK Maker using the mouse sequences of
the eight Edg receptors. Branch length indicates the relatedness of two
sequences. Asterisks indicate the members of the different families expressed in
oocytes.
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Ovary fragments were surgically removed from PMSG-primed X. laevis,
and defolliculated oocytes were isolated after treatment with collagenase (2.5
mg/ml) in MBS buffer [10 mM HEPES (pH 7.4), 88 mM NaCl, 1 mM KCl,
0.82 mM MgSO4, 2.4 mM Na2 HCO3] for 1–1.5 h. Dumont Stage VI oocytes
were selected for all experiments. Oocyte selection and experiments were
carried out in OR2 solution [5 mM HEPES (pH 7.8), 82.5 mM NaCl, 2.5 mM
KCl, 1 mM CaCl2, 1 mM MgCl2, 1 mM Na2HPO4]. Gpr12 and Gpr3 cRNA
were in vitro transcribed from the pGEMHE+SP vector using T7-RNA-
polymerase and a NheI-linearized plasmid. The mRNAs or H2O (vehicle) were
injected using a micromanipulator (Narishige USA, Long Island, NY) into
defolliculated Xenopus oocytes. Sixteen hours after injecting increasing
concentrations of Gpr12 or Gpr3 mRNA (ranging from 0.2 to 5 ng/oocyte
in 50 nl), the oocytes were stimulated with 500 nM progesterone. Resumption
of meiosis was scored every hour, up to 10 h, by the appearance of a white spot
on the animal pole of the oocyte.
Statistical analyses
Values were compared by Student’s t test, and P < 0.05 was considered
statistically significant.
Results
Screening for mRNAs coding for GPCRs expressed in mouse
and rat oocytes
Three independent strategies were used to identify GPCR
mRNAs expressed in rodent GV oocytes. Degenerate primers
corresponding to the most conserved regions of transmembrane
domains 3 and 6 in the GPCR families (Fredriksson et al., 2003)
were designed and used for RT-PCR with rat or mouse oocyte
RNA. In addition, microarray data from mouse GV and MII
oocytes were searched for GPCR RNA expression (Wang et al.,
2004). Finally, available EST databases generated by sequenc-
ing of mouse oocyte libraries, including data from a library
that we have recently generated (NIH_MGC_256, NIH_
MGC_257), were used for GPCR data mining. RT-PCR with
degenerate primers on rat GVoocyte mRNA yielded sequences
corresponding to Adora2a (adenosine A2a receptor) and to
Gpr12, a receptor that binds lysophospholipids (Ignatov et al.,
2003). The expression of these mRNAs in the rat oocyte was
consistent with the data retrieved by microarray and EST data
mining of mouse oocyte libraries. A summary of the GPCR
mRNAs retrieved by these three methods is reported in Table 1.
From this survey, it is evident that GPCRs corresponding to
different families, including family 1 and family 2, as well as the
olfactory receptor family, are likely expressed in the quiescent
oocyte (Table 1). Some of the receptors such as Gpr56, Gpr44,
and Gpr19 are orphan receptors with unknown ligands (Liu et
al., 1999). The expression of the adenosine receptor A2a/b
mRNA is consistent with previous reports of the effects of
adenosine on oocytes (Salustri et al., 1988; Tornell et al., 1990;
Eppig et al., 1985). In addition, expression of mRNA for Gpr56
in oocytes has been previously determined (Stanton and Green,
2001). This receptor belongs to the family of secretin receptors,
even though a ligand has not been identified and a possible
function in oocytes has not been explored (Liu et al., 1999).Analysis of GPCR families expressed by homology cluster-
ing showed that Gpr3, Gpr12, and Edg3 and alpha MSH
receptors belong to the same subfamily (Fig. 1). Whereas
melanocortin receptors 1 and 5 use peptides as ligands, GPR3,
GPR12, and EDG3 are receptors for the lipids S1P and SPC
(Kostenis, 2004). In view of their properties and their binding to
ligands produced locally and ubiquitously, we focused on the
expression and function ofGPR3,GPR12, and EDG3 in oocytes.
Fig. 2. Expression of GPCR mRNA in oocytes and surrounding somatic cells
(A) RT-PCR of RNA from mouse oocytes, cumulus cells, and mural granulosa
cells was performed by using primers specific for Gpr12, Gpr3, Edg3, and
Gpr56. Control PCRs for h-actin were carried out to ensure that an identica
amount of cDNA was used for each cell type and gene. The data shown are
representative of RT-PCRs from four different preparations of RNA and cDNA
(B) The intensity of the ethidium-bromide-stained bands was analyzed by NIH
Image software. Data are expressed as the ratios of the intensity of each band to
the b-actin band. The ratio of intensity of the oocyte was set as 100%. (C) Gpr3
and Gpr12 expression in rat and mouse oocytes was compared by RT-PCR with
gene-specific primers on identical amounts of cDNA. In parallel, PCRs were
performed with h-actin primers to monitor for the amount of cDNA from rat (a
and mouse (b) oocytes used. RT-PCR was also performed using rat (c) and
mouse (d) brain as positive controls for the primers.
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compartments of rodent ovaries
To further investigate the expression of these receptors in
different cells of the ovarian follicle, RT-PCR was performed
with specific primers based on the mRNA sequences of Gpr3,
Gpr12, and Edg3. Gpr56 was used for comparison. RT-PCRs
were performed on RNA from mouse oocytes, cumulus, and
mural granulosa cells after RNA extraction (data not shown) or
using procedures that do not require the isolation of RNA (Figs.
2A, B). Both methods yielded similar qualitative results. Unlike
Gpr56, which is expressed in all three cellular compartments,
Gpr3, Gpr12, and Edg3, showed specificity in their pattern of
expression. Whereas Gpr12 is expressed exclusively in oocytes,
with undetectable expression in somatic cells, Gpr3 and Edg3
mRNAs are expressed mainly in oocytes and to a lesser extent
in cumulus cells. Comparison by density measurements of the
PCR products on ethidium bromide-stained agarose gels
indicated that the expression of Gpr3 and Edg3 in cumulus
cells is approximately 10% of that found in oocytes. In addition,
semiquantitative comparison of Gpr3 and Gpr12 expression in
mouse oocytes indicated that Gpr3 mRNA is about fourfold
more abundant than Gpr12. On the contrary, only Gpr12
expression was observed when rat oocytes were used (Fig. 2C).
This cellular pattern of expression within the follicle was
confirmed by in situ hybridization with Gpr3 (Figs. 3A, B) and
Gpr12 (Figs. 3C, D) antisense probes in mouse and rat ovaries,
respectively. Major signal was observed in the oocytes from
follicles at different stages of development, with Gpr3 being
readily detectable in mouse oocytes and Gpr12 in rat oocytes.
Gpr3 expression could not be detected in rat ovaries (data not
shown), and Gpr12 mRNA expression was barely above
background in mouse ovaries when compared to Gpr12-null
ovaries (data not shown). Signal was also evident on cells in the
somatic compartment; however, it is unclear whether this signal
is above background level. In situ hybridization performed with
the sense probe showed a uniform pattern of distribution of the
silver grains throughout the tissue (data not shown).
Expression of Gpr3 and Gpr12 mRNA is dependent on cAMP
signaling in the oocyte
Oocytes from the Pde3a-KO mice are arrested in meiotic
prophase because of persistent high levels of cAMP (Masciarelli
et al., 2004). In these oocytes, the levels of cAMP are chronically
elevated because there is little or no cAMP-PDE activity.
However, the increase in cAMP in the Pde3a-KO is modest (less
than twofold) in comparison with the increase in cAMP
observed when PDE3 is acutely inhibited with cilostamide (data
not shown). This suggested that a compensatory decrease in
adenylyl cyclase activity and/or signal transduction components
is present in these oocytes; such negative feedback regulation
involves decreased expression (downregulation) of GPCRs that
signal through adenylyl cyclase activation. An increase in cAMP
signaling is compensated by downregulation of receptor
expression, whereas a decrease in cAMP signaling is followed
by an increase in receptor density (Luttrell and Lefkowitz,.
l
.
)2002). We therefore used these genetically altered oocytes to test
whether a chronic increase in cAMP has an impact on Gpr3 and
Gpr12 mRNA expression. To test this possibility, 1000–2000
Fig. 4. Downregulation of Gpr3 and Gpr12 mRNAs in Pde3a-null oocytes. (A)
RT-PCR was performed on equal amounts of cDNA from wild-type and
Pde3a/ denuded oocytes. The expression of b-actin was used as a control.
Specific primers for Gpr12, Gpr3, and Gpr56 were used for different cycles of
amplification. A representative experiment of the three performed is reported.
(B) The intensities of the ethidium-bromide-stained bands were analyzed by
NIH Image. Data are expressed as the ratio of the intensities of the Gpcr to the
b-actin mRNA. Error bars are the mean T SEM of three determinations. The
decrease in expression of Gpr3 and Gpr12 is statistically significant (P <
0.005), whereas the expression of Gpr56 was not statistically different from
control.
Fig. 3. Pattern of Gpr3 and Gpr12 expression in rodent ovaries using in situ
hybridization. Ovaries were excised from PMSG-primed immature mice and
rats and fixed and sectioned as detailed in the Materials and methods. Mouse
(A, B) and rat (C, D) sections were hybridized with antisense Gpr3 (A, B) and
Gpr12 (C, D) RNAs, respectively, and processed in an identical manner.
Sections hybridized with the corresponding sense RNA showed a uniform
distribution of the grains throughout the section (data not shown). Arrows
indicate oocytes in follicles at different stages of development. Representative
sections of the three experiments performed for each gene and species are
shown.
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deficient and wild-type littermates were isolated, RNA extracted
by the TRIzol method, and the expression of Gpr3, Gpr12, and
Gpr56 were investigated using semiquantitative measurements
(Fig. 4). Whereas Gpr56 levels were not significantly changed,
the expression of both Gpr3 and Gpr12 was decreased by more
than 50% in the Pde3a-deficient oocytes (Fig. 4).
GPR3 and GPR12 display constitutive activity toward Gs when
overexpressed in somatic cells and in frog and mouse oocytes
A distinctive feature of the GPR3/GPR12 family is that they
show constitutive activity toward Gs when expressed in several
heterologous systems (Eggerickx et al., 1995; Uhlenbrock et al.,
2002). This property of the two receptors was confirmed by
expressing GPR12 and GPR3 in COS7 cells (Fig. 5). Expression
of either receptor produced a large increase in cAMP
production, whereas the expression of two other receptors
linked to Gs and cAMP showed no activity in the absence of
ligand (Fig. 5A). The increase in cAMP following GPR3 or
GPR12 expression was present whether the transfection was
performed with constructs with the native Gpr sequence or a
fusion with a synthetic signal peptide sequence, suggesting that
the constitutive activity is observed at a wide range of receptor
expression levels. Upon treatment of the transfected cells with
S1P, and to a lesser degree SPC, a small but significant increase
in cAMP accumulation was observed (Fig. 5B).To determine whether this property of GPR3 and GPR12 is
sufficient to maintain the meiotic blockade, mouse oocytes
were maintained in meiotic arrest with the PDE3 selective
inhibitor cilostamide (10 AM) and injected with Gpr3 and
Gpr12 mRNAs. After 4 h, oocytes were washed free of the
inhibitor and spontaneous maturation was observed for the
following 24 h (Fig. 6A). Noninjected oocytes or oocytes
injected with Gfp mRNA underwent spontaneous maturation,
whereas, in oocytes injected with either Gpr3 or Gpr12,
spontaneous maturation was prevented, with Gpr12 being less
effective than Gpr3 (Fig. 6A).
In a parallel experiment, the two receptors were
expressed in frog oocytes. Unlike mammalian oocytes, frog
oocytes do not undergo spontaneous meiotic maturation
when isolated from their follicle environment, and proges-
terone stimulation is required to induce reentry into the cell
cycle. Expression of increasing concentrations of either
Gpr3 or Gpr12 mRNA produced a concentration-dependent
block in oocyte maturation (Fig. 6B). Conversely, expres-
sion of FSHR had no effect on oocyte maturation induced
by progesterone.
Fig. 5. Increased cAMP levels in cells expressing GPR3 and GPR12. (A) COS7
cells were transfected with either Gpr3, Gpr12, Fshr, or Adrb2 expression
vectors. Empty vector was used as a control. Forty-eight hours after
transfection, cells were rinsed and serum-starved for 24 h. At the end of the
incubation, cells were harvested in 0.1% TCA in ethanol, and cAMP was
measured as detailed in Materials and methods. Each point is the mean T SEM
of three plates. A representative experiment of the three performed is reported.
(B) Transfected cells were incubated for an additional 30 min with 0.5 mM
IBMX in the absence or presence of 10 AM S1P and were harvested as above
for cAMP measurement. Error bars are the mean T SEM of five separate
experiments. Using paired t tests, P < 0.01 for the effect of S1P on Gpr12 and
on Gpr3.
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oligonucleotides affects meiotic maturation
To further define whether GPR3 and GPR12 in mouse and
rat oocytes have overlapping functions in meiosis, down-
regulation of the two receptors was induced using morpholino
oligonucleotides (MO) (Fig. 7). Oocytes maintained in meiotic
arrest by incubation in hypoxanthine (4.5 mM) were injected
with antisense morpholino oligonucleotides corresponding to
Gpr3 and Gpr12, and the meiotic progression was followed upto 48 h (Fig. 7). In the mouse, Gpr3MO injection caused
oocyte maturation (Fig. 7A), whereas Gpr12MO was ineffec-
tive. Conversely, Gpr12MO but not Gpr3MO produced
meiotic resumption in rat oocytes (Fig. 7B). Most of the
oocytes injected with scrambled oligonucleotides and the
noninjected oocytes remained arrested in GV stage for the
entire culture period, similar to that previously observed with
hypoxanthine (Eppig et al., 1985). The effect of GPR3
knockdown in the mouse is consistent with the mouse Gpr3
knockout data (Mehlmann et al., 2004). This species-specific
difference in GPR3 and GPR12 downregulation underscores
the importance of GPR12 in the rat and strongly suggests that
the two receptors have complementary functions.
A ligand for GPR3/GPR12 delays spontaneous meiotic
maturation
To test whether a GPR3/GPR12 ligand impacts meiotic
maturation, ovaries were excised from immature PMSG-treated
mice. Oocytes were isolated in the absence or presence of 1–
10 AM SPC or S1P, or 10 AM sphingomyelin (SM) as a
negative control, and the time course of meiotic maturation was
followed using the time of follicle puncture as 0 time (Figs. 8A,
B). Oocytes collected in 10 AM SPC or S1P showed a
consistent and significant delay in oocyte maturation, whereas
oocytes collected in SM, a phospholipid present in the lipid
rafts of the plasma membrane but not thought to be a ligand for
GPCRs, matured at the same rate as control oocytes. In the five
different experiments performed after isolation in the presence
of 10 AM SPC, maturation at 75 min was only 13% compared
with 59% in the control oocytes (P < 0.001) (Fig. 8B).
Experiments done with S1P produced similar results with
significant inhibition (P < 0.05) although more variable,
possibly because of the physical properties of the compound.
These experiments suggest that the activity of GPR3 and
GPR12 expressed in the oocyte is potentiated by a ligand.
Impact of genetic Gpr12 ablation on oocyte maturation in vivo
The data described above are consistent with the hypothesis
that expression of GPR3 and GPR12 in oocytes is involved in
maintaining cAMP levels sufficient for meiotic arrest. This
possibility was further tested by investigating whether a leaky
meiotic arrest follows Gpr12 ablation in mice. However,
analysis of the meiotic stage of oocytes in antral follicles from
two PMSG-treated immature and two adult Gpr12-null mice
showed no signs of precocious maturation. Oocytes present in
antral follicles had a well-formed GV. This indicated that the
constitutive activity of GPR12 is not required to maintain
meiotic arrest by itself and/or that compensation byGPR3 occurs
in the Gpr12-KO mice. Ablation of Gpr3 produces a phenotype
of precocious meiotic resumption (Mehlmann et al., 2004).
Discussion
With the present study, we provide evidence for the
expression of an array of GPCRs in rodent oocytes, opening
Fig. 6. Expression of GPR3 and GPR12 in mouse and frog oocytes blocks spontaneous or progesterone-stimulated meiotic resumption. (A) Denuded mouse oocytes
maintained in GV with 10 AM cilostamide were injected with Gfp, Gpr3, or Gpr12 cRNA or not injected (NI control). After 4 h, oocytes were washed and placed in
medium without cilostamide under oil and scored for maturation up to 24 h. Percentage maturation is shown for oocytes injected in three different experiments
(mean T SEM). (B) Stage VI Xenopus oocytes were injected with increasing concentrations of cRNA coding for Gpr3, Gpr12, or Fshr. Twelve hours after the
injection, oocytes were treated with 500 nM progesterone, and oocyte maturation scored after 6 h. A representative experiment of the three performed is reported.
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functions to numerous extracellular cues present in the
follicular environment. In view of the properties of GPR3
and GPR12 and their pattern of expression in the follicle, we
propose that these receptors are involved in the control of
cAMP accumulation in the oocyte and are likely involved in
the maintenance of meiotic arrest. That GPR3 and GPR12 are
implicated in cAMP signaling in oocytes is consistent with the
observation that their mRNA expression is reduced when
cAMP is chronically increased in oocytes. Because the
constitutive activity of these receptors is sufficient to prevent
maturation in mouse and Xenopus oocytes, we surmised that
their activity is also sufficient for maintaining the meiotic arrest
in the follicle. In view of the absence of an oocyte meiotic
maturation phenotype in the Gpr12-null mice, we inferred that
GPR3 is the predominant receptor signaling meiotic arrest in
mice. Conversely, it is likely that GPR12 plays a predominant
role in meiotic arrest in rat oocytes. Indeed, in vitro data of
downregulation of GPR3 and GPR12 in mouse and rat oocytes
using morpholino-modified oligonucleotides are consistent
with this hypothesis. Thus, our findings complement and
extend a recent report that meiotic arrest is defective in mice
deficient in Gpr3 (Mehlmann et al., 2004).More than 30 GPCR mRNAs were detected in mouse and
rat oocytes by the three strategies used. The expression of
Gpr3 and Gpr12, as well as Gpr56, was detected by
microarray analysis, RT-PCR with degenerate and gene-
specific primers, as well as by EST database scanning. Edg3
expression was detected by microarray analysis and confirmed
by RT-PCR. The expression of the other GPRC genes is
inferred from the microarray data and, in some instances, by
EST retrieval from oocyte or egg libraries. Although the
expression of these additional GPCRs needs to be further
confirmed, it is likely that several seven transmembrane
receptors coupled to different G proteins are functional in
oocytes. In many instances, the ligands for these receptors are
not known, as for GPR1, GPR19, and GPR56, as well as for
the olfactory receptors. GPR56 is a secretin-like receptor
implicated in brain development as inferred by linkage with
bilateral fronto-parietal polymicrogyria (Piao et al., 2004), and
Gpr56 mRNA has been previously detected in oocytes
(Stanton and Green, 2001). Here, we have confirmed this
expression by RT-PCR, as well as by microarray and EST
database scanning. In addition to its presence in the oocyte,
Gpr56 mRNA is also detected in mural granulosa and cumulus
cells by RT-PCR with specific primers. This receptor is
Fig. 7. Effect of downregulation of GPR3 and GPR12 on mouse and rat oocyte meiotic arrest. Oocytes were collected in medium supplemented with 4.5 mM
hypoxanthine to prevent spontaneous maturation. Groups of oocytes were injected with either a scrambled morpholino oligonucleotide (control oligo) or with
morpholino oligonucleotides corresponding to Gpr3 (Gpr3MO) or Gpr12 (Gpr12MO). A group of noninjected oocytes was used as a further control for the
injection. Oocytes were maintained in medium with hypoxanthine for up to 48 h and the state of meiotic progression evaluated by Hoffman interference microscopy.
Data are reported as percentage of oocytes that resumed meiosis (GVBD); the numbers above each bar represent the total number of oocytes injected in at least three
separate experiments done on different days with different batches of oocytes (***P < 0.001).
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directly signal through cAMP; thus, its function in the oocyte
remains to be determined. Conversely, adenosine effects on
oocyte maturation have been previously reported (Salustri et
al., 1988; Tornell et al., 1990; Eppig et al., 1985). It is then
likely that these effects are exerted through the A2A and/or
A2B receptors, whose expression we have detected by two
approaches. However, the exact physiological significance of
this expression is unclear as the Adora2a-KO mice do not
display a fertility phenotype (Ledent et al., 1997).
The expression of Gpr3 and Gpr12 mRNAs was detected
by RT-PCR in denuded mouse oocytes. That the detection of
these mRNAs is the consequence of contamination from
somatic cells is unlikely, in view of their low level of
expression in the somatic compartment. Moreover, in situ
hybridization showed a predominant signal on the oocytes with
Gpr3 probes, whereas the signal on cumulus or mural
granulosa cells was low and difficult to distinguish from
background. Rat oocytes expressed Gpr12 mRNA, whereas
Gpr3 mRNA could not be detected either by RT-PCR or in situ
hybridization. Because of the different properties of the sets of
primers used, it is not possible to accurately assess the relative
steady state levels of the Gpr3 and Gpr12 mRNAs by RT-PCR
in oocytes nor can microarray data provide absolute quantita-
tive measurements. Nevertheless, on the basis of all our
findings, it is tempting to propose that Gpr3 is expressed at
higher levels than Gpr12 in mouse oocytes with a ratio of 4:1,
whereas Gpr12 is the predominant receptor expressed in rat
oocytes. These different levels of expression are consistent
with the morpholino effects and may explain the absence of a
meiotic phenotype in the Gpr12-null mice.An involvement of GPR3 and GPR12 in the control of
cAMP levels in oocytes is consistent with the observation that
the expression of these receptors is decreased in the Pde3a-null
mice. These oocytes are arrested in meiotic prophase because
of a persistent increase in cAMP that follows PDE ablation
(Masciarelli et al., 2004). We observed that the increase in
cAMP in the Pde3a-KO is modest (less than twofold) in
comparison with the increase in cAMP observed when PDE3 is
acutely inhibited with cilostamide. This finding is consistent
with the observation that the mRNA for Gpr3 and Gpr12 is
decreased in these oocytes. We propose that the chronic
increase in cAMP that follows PDE3A ablation triggers a
compensatory downregulation of the receptors coupled to Gs
and adenylyl cyclase in the oocyte. This is a well-established
regulatory loop in somatic cells essential for the control of
receptor density and endocrine homeostasis (Luttrell and
Lefkowitz, 2002).
Overexpression of GPR3 and GPR12 in COS7 cells causes
a large increase in cAMP accumulation, a finding consistent
with previous reports (Eggerickx et al., 1995; Uhlenbrock et
al., 2002). Similarly, overexpression of either receptor in frog
and mouse oocytes prevents progesterone-induced maturation
and spontaneous maturation, respectively. This finding strongly
suggests that these receptors have sufficient intrinsic activity to
maintain meiotic arrest and have largely overlapping proper-
ties. However, Gpr12 gene inactivation in the mouse fails to
produce a phenotype of precocious oocyte maturation, whereas
Gpr3 inactivation causes a clear phenotype of leaky meiotic
arrest (Mehlmann et al., 2004). Although the level of
expression of the corresponding proteins could not be assessed
in oocytes, differences in concentrations of the two receptors in
Fig. 8. Effects of SPC, S1P and SM on the time course of spontaneous
maturation in mouse oocytes. (A) Denuded oocytes were collected in L-15
medium with 0.7% PVP with or without 1 or 10 AM SPC or 10 AM S1P or
SM and then placed in 25 Al drops under mineral oil. Oocytes were scored for
meiotic maturation as described in Materials and methods with time 0 set as
the time of puncture of follicles. (B) Summary of the stage of maturation of
oocytes treated with 10 AM SPC, S1P, or SM 75 min after isolation. The
differences between the control and SPC and S1P groups at 75 min are
statistically significant (P < 0.001 and P < 0.05, respectively). The data
represent the mean T SEM of 4 to 7 experiments.
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maturation. In the same vein, GPR12 is most likely the GPCR
involved in maintaining meiotic arrest in rat oocytes. Whereas
Gpr12 mRNA was detected in both mouse and rat oocytes by
RT-PCR, Gpr3 mRNA could not be detected in rat oocytes.
Assuming that the two receptors have similar functions, we
predict that in vivo downregulation in rat oocytes should
produce an effect similar to that produced by the Gpr3
homologous recombination on mouse oocytes. Indeed, our
data on downregulation of GPR12 in rat oocytes in vitro are
seemingly consistent with this hypothesis. Thus, GPR12 plays
a role in the control of meiotic arrest in the rat and possibly in
the mouse. Interestingly, the number of competent oocytesundergoing premature maturation in the Gpr3-null adult mice
is 60–70% (Mehlmann et al., 2004) opening the possibility
that another receptor, likely GPR12, compensates for the loss
of GPR3. Similarly, the absence of a meiotic phenotype in the
Gpr12-KO mouse may be entirely due to compensation by the
GPR3 receptor expression. Finally, Edg3 ablation produces
only a minor decrease in litter size, even though the mRNA for
this receptor is detected in oocytes (Ishii et al., 2001). It
remains to be determined whether subtle effects on meiotic
arrest are present in females deficient in this gene. It is unclear
whether EDG3 receptors affect cAMP signaling. EDG3
produces only a small increase in cAMP when expressed in a
heterologous system, and pertussis toxin inclusion is required
to detect this effect, suggesting that also this receptor may
signal through Gs (Kon et al., 1999). Thus, a role for EDG3 in
the control of cAMP levels in oocytes cannot be excluded at
this point.
Together with the EDG (also known as S1P1–5) subfamily,
GPR3, GPR6, and GPR12 are a subfamily of GPCR receptors
that recognize sphingosine-1-phosphate or sphingosylpho-
sphorylcholine as ligands. These are lipid mediators known
to have a wide array of pleiotropic effects in the most diverse
regions of the body, including effects on cell migration,
angiogenesis, immune cell function, and cardiac and central
nervous system development (Kostenis, 2004). Sphingolipids
are ubiquitous constituents of the eukaryotic membranes. They
include the acylated sphingoid base ceramide and sphingosine-
1-phosphate, which is generated via phosphorylation of
sphingosine by a sphingosine 1 kinase (Hannun et al., 2001).
In frog oocytes, ceramide causes meiotic resumption (Strum et
al., 1995) and progesterone affects lipid synthesis (Morrill and
Kostellow, 1999), suggesting that metabolites of these lipids
may function during meiotic maturation in frogs. S1P has been
shown to prevent apoptosis of oocytes exposed to chemother-
apeutic damage (Morita et al., 2000). In view of their
ubiquitous presence, it is most likely that S1P and related
ligands are present in the follicular environment and accessible
to the oocyte. Thus, it is possible that GPR3/12 occupancy by
these ligands contributes to maintain meiotic arrest in oocytes
in the follicle. The decrease in ligand concentration when the
oocyte is removed from the follicular environment may
decrease GPR3/GPR12 activity, allowing spontaneous matura-
tion. However, the two putative ligands we used had modest
effects on oocyte maturation when added at concentrations up
to 10 AM. This incomplete effect is consistent with the finding
that these ligands produce only a small increase in cAMP
accumulation when GPR3 or GPR12 are expressed in a
heterologous system. A caveat in the interpretation of these
findings is that the ligands may be rapidly metabolized under
the culture conditions used. It also cannot be ruled out that they
may be sequestered into lipophilic compartments or bound to a
carrier protein. The experiments were performed in the absence
of serum, thus decreasing the possibility of carrier protein
interference. The zona pellucida, however, could represent a
barrier for the diffusion of these ligands. Therefore, whether
lipid binding to GPR3 or GPR12 contributes to the prevention
of meiotic maturation remains an unresolved issue.
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virtue of their constitutive activity in the absence of a ligand,
and the interaction with Gs may be sufficient to increase cAMP
to levels that preclude maturation of the competent oocyte
within the follicle. The reason why this activity is not sufficient
to prevent spontaneous maturation is unclear at present. We
have shown that during spontaneous maturation an increase in
PDE3 activity is detected in the oocytes (Richard et al., 2001).
This increased activity may be sufficient to overcome the
constitutive activity of the two receptors. Furthermore, it has
been previously proposed that oocytes do not produce
sufficient cAMP and gap junctions are essential for maintaining
meiotic arrest by allowing diffusion of cAMP from the somatic
compartment (Dekel et al., 1981). According to this model,
meiotic maturation occurs because of closure of the gap
junction following the LH surge (Sela-Abramovich et al.,
2005). It is possible that cAMP diffusion plays a role in both
meiotic arrest and meiotic maturation and that this mechanism
is complementary to intra-oocyte production of cAMP due to
GPR3/12 expression. However, the following findings are in
conflict with a primary role of gap junctions in maintaining
cAMP in oocytes. Pde3a-deficient oocytes are maintained in
meiotic arrest even 24 h after release from the follicle, which
would not be possible if oocytes did not have the capacity to
produce cAMP. Moreover, the effects of Adcy3 genetic ablation
(Horner et al., 2003), as well as inactivation of Gs by antibody
injection into oocytes within the follicle (Mehlmann et al.,
2002), strongly support the view that the oocyte itself produces
sufficient cAMP to maintain meiotic arrest. Further studies are
required to assess whether multiple mechanisms intrinsic and
extrinsic to the oocyte cooperate in the control of the pool of
cAMP that signals meiotic arrest.
We have recently reported that the LH surge activates the
expression of EGF-like growth factors and that these factors
recapitulate many of the LH effects, including oocyte
maturation (Park et al., 2004). These factors do not act directly
on oocytes since denuded oocytes maintained in meiotic arrest
with hypoxanthine do not mature in the presence of these
growth factors, whereas maturation can be induced in
cumulus–oocyte complexes. Therefore, it is possible that these
EGF-like growth factors modify the cumulus cell function and
that these in turn affect oocyte cAMP by modulating the
activity of GPR3 and/or GPR12. Indeed, crosstalk between
EGF and lipid signaling is well established (Daub et al., 1996),
and EGF action has been associated with major changes in
lipid metabolism and signaling (Le Stunff et al., 2004).
Therefore, a link between the EGF network and GRP3/
GPR12 signaling may be possible.
In summary, we have demonstrated that a number of seven
transmembrane domain receptors are expressed in mouse and
rat oocytes. Of these receptors, GPR3 and GPR12 appear to
stimulate Gs activity in a ligand-independent fashion, at least in
a reconstitution system. Although we have shown that this
property is sufficient to prevent maturation in frog and mouse
oocytes and their activity is required to maintain the meiotic
arrest in vitro, it remains to be determined how the endogenous
receptors function. Their coupling to different G proteins in theoocyte and the effect of ligands on this coupling remain to be
determined. In view of the differences in expression of these
receptors in mouse and rat, we propose that both GPR3 and
GPR12 play a critical role in the control of cAMP levels in the
oocyte and in meiotic arrest.
Note added in proof
During the revision of the manuscript, an additional study
was published documenting that Gpr3 ablation produces
incomplete meiotic maturation and premature ovarian aging
in the mouse. (Ledent C, Demeestere I, Blum D, Petermans J,
Hamalainen T, Smits G, Vassart G. Premature ovarian aging in
mice deficient for Gpr3. Proc Natl Acad Sci USA. 2005
102:8922–8926.)
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